Study of potential new treatment for mesothelioma open to patients

September 15, 2016

The Baylor College of Medicine Mesothelioma Treatment Center at Baylor St. Luke's Medical Center has begun enrolling patients in a clinical research study looking at an investigational drug in patients with malignant pleural mesothelioma who have started on chemotherapy or whose cancer has progressed after initial chemotherapy.

Pleural mesothelioma is a rare and aggressive that develops in the pleura, a thin layer of tissue that surrounds the lungs. The most common cause of malignant pleural mesothelioma is exposure to industrial pollutants, predominantly asbestos, a fiber-like material that was used in some industries before its toxic qualities were understood. This disease affects people who were exposed to asbestos in the workplace and their family members.

"The disease is particularly challenging because by the time it's detected – often 20 to 40 years after exposure to the cancer-causing asbestos – the disease can be very advanced," said Dr. David Sugarbaker, professor of surgery, chief of the division of thoracic surgery and director of the Mesothelioma Treatment Center and Lung Institute at Baylor. "Currently, available treatment options are limited for patients whose mesothelioma has progressed or does not respond after initial anticancer treatment, so clinical research is highly important in helping advance our understanding of how to treat it."

The purpose of this Phase II clinical study is to assess the safety and effectiveness of an investigational cancer drug versus a commonly used medication in people with that has advanced and/or metastasized and that is refractory (stopped responding or did not respond to previous ). This binds to a protein called mesothelin, which can be found on the surface of some cancer cells, and releases chemotherapy to the tumor to try to slow or stop the growth of cancer cells.

The investigational drug is currently only available through studies such as this one.

Explore further: Mesothelioma surgery improves quality of life

More information: Details about this clinical study can be found online: clinicaltrials.gov/ct2/show/NC … ab+ravtansine&rank=4

Related Stories

Mesothelioma surgery improves quality of life

June 9, 2016
Although surgery can prolong the lives of patients with an aggressive type of cancer called malignant pleural mesothelioma, many patients avoid the operation for fear it will degrade their quality of life.

Researchers find potential new target to treat malignant pleural mesothelioma

July 25, 2013
Malignant mesothelioma is a rare asbestos-associated malignancy with limited therapeutic options. Despite advances in the treatment, the median survival remains 12 months from the time of diagnosis. Increased understanding ...

Renal cancer drug temsirolimus shows promise against mesothelioma

May 1, 2011
A drug commonly used to treat kidney cancer may increase the effectiveness of chemotherapy for mesothelioma, according to a study published in the May issue of the Journal of Thoracic Oncology.

Statistical model may identify patients most likely to benefit from surgery for mesothelioma

September 8, 2015
A new statistical model may help predict which patients are most likely to receive life-extending benefits from surgical treatment for malignant pleural mesothelioma (MPM), according to an article in the September 2015 issue ...

Overlooked lymph nodes in rib cage have prognostic power for mesothelioma patients

October 28, 2013
For the first time, researchers from the Perelman School of Medicine at the University of Pennsylvania have shown the predictive power of a group of overlooked lymph nodes—known as the posterior intercostal lymph nodes—that ...

Immunotherapy drug pembrolizumab shows promise for mesothelioma patients

April 20, 2015
The PD-1 inhibitor pembrolizumab, a cancer immunotherapy drug, shrank or halted growth of tumors in 76 percent of patients with pleural mesothelioma, a rare and deadly form of cancer that arises in the outer lining of the ...

Recommended for you

Researchers identify gene variants linked to a high-risk children's cancer

September 25, 2017
Pediatric researchers investigating the childhood cancer neuroblastoma have identified common gene variants that raise the risk of an aggressive form of that disease. The discovery may assist doctors in better diagnosing ...

Prostaglandin E1 inhibits leukemia stem cells

September 25, 2017
Two drugs, already approved for safe use in people, may be able to improve therapy for chronic myeloid leukemia (CML), a blood cancer that affects myeloid cells, according to results from a University of Iowa study in mice.

MRI contrast agent locates and distinguishes aggressive from slow-growing breast cancer

September 25, 2017
A new magnetic resonance imaging (MRI) contrast agent being tested by researchers at Case Western Reserve University not only pinpoints breast cancers at early stages but differentiates between aggressive and slow-growing ...

Cancer vaccines need to target T cells that can persist in the long fight against cancer

September 25, 2017
Cancer vaccines may need to better target T cells that can hold up to the long fight against cancer, scientists report.

Lung cancer treatment could be having negative health effect on hearts

September 25, 2017
Radiotherapy treatment for lung cancer could have a negative effect on the health of your heart new research has found.

Alternative splicing, an important mechanism for cancer

September 22, 2017
Cancer, which is one of the leading causes of death worldwide, arises from the disruption of essential mechanisms of the normal cell life cycle, such as replication control, DNA repair and cell death. Thanks to the advances ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.